Aalberts: highlights ING Benelux Conference Brussels 2024, Ackermans & Van Haaren: Highlights ING Benelux Conference Brussels,Ackermans & Van Haaren: Strong operational performance of underlying companies and guidance fine-tuned upwards, AMG: Highlights ING Benelux Conference Brussels, Aperam: Highlights ING Benelux Conference Brussels, Arcadis: Highlights ING Benelux conference, Azelis: Highlights ING Benelux Conference Brussels, Bekaert: Guidance cut and €200m buyback as sweetener, CFE: No new...
With 2 changes in our Dynamic Top Pick list (we add Azelis and we remove Solvay) we maintain a defensive stance on the market for 2H24. The long anticipated interest rate cuts by central banks have finally started. The Trump election victory in the US does not bode well for European stocks as he favours a protectionist course. Although industrial companies with a US base could actually benefit. Cleantech names with exposure to the US could also suffer (unless owned by E.Musk). We expect the US ...
In this note we come back to the 3Q24 results which were beside the FX headwind decent and showed a return to organic growth. For FY24 we lower our EBITA expectations, due to FX headwinds and lower acquisitional growth. This while the more important organic growth and gross profit margin improved. Our segment overview shows that across regions most end markets improved. We forecast that 4Q24 will be the first quarter to report organic growth in all regions since 3Q22. Furthermore, we highlight t...
>Back to organic growth, albeit at rather careful levels - Azelis’ end-markets are showing signs of a recovery in volumes, albeit at a still very prudent pace it seems. The company generated Q3 24 revenues of € 1,054m, c. +2% yoy and -2% vs ccs. Group organic growth in the quarter was positive (+2.8% yoy) for the first time in roughly two years, an indication that markets are slowly recovering, albeit from a relatively easy comp base. Operating EBITA for the quarter w...
Acomo: Hot Chocolate. Azelis: 3Q24 not flawless, but organic growth is back. BE Semiconductor Industries: 3Q24 results, putting its money where its mouth is. Ebusco: Rigorous turnaround plan, but many liquidity related concerns; recommendation moves to Under Review. GBL: Looking to take vitamins. Kinepolis: Solid 3Q24 attendance, in line, confident in the movie outlook for 4Q24, 2025. Ontex: Guidance Stumble. Unilever: Momentum maintained. Vastned: End of the disposal program, wa...
AkzoNobel: Slight miss on 3Q24, larger miss on year-end leverage Allfunds Group PLC: Strong NNM beat ASM International: Preview 3Q24; probably not too bad Azelis: 3Q24 results preview Heineken: Yet another miss Kinepolis: 3Q24 preview Philips: Preview 3Q24, some upside risk to margins Proximus: 3Q24 preview Events Calendar
A recent investor event provided comfort on Azelis' ability to capture the attractive growth momentum of the specialty chemicals distribution market and extend its M&A strategy, while further improving margins. We maintain our BUY and €29 per share target price, with organic comps now demonstrably easing and ahead of a cautious organic recovery in select end-markets. Our positive stance is further supported by an attractive discount of +35% to key peer IMCD.
In this note we go in detail over our takeaways of the site visit in Istanbul and adjust our numbers accordingly. As expected, no new guidance was provided. A logical assumption based on remarks from mgmt., is 4% revenue growth and an increase in EBITA margin of at least 10bp annually. The event was well attended and we left with a positive feeling. We expect less operational leverage on the Gross profit margin, more leverage on the operating expenses and benefits from M&A. We reiterate our Buy ...
Azelis' 2Q24 results confirmed early green shoots amidst a still patchy economic backdrop. We make minor changes to our estimates and raise our target price to €29, mainly driven by higher peer multiples. We reiterate our BUY, as we believe Azelis' business model is intact as the industry recovers from an extended downcycle, with our positive stance supported by Azelis' attractive discount of 35% to key peer IMCD.
ING Benelux Conference London: Aalberts, Arcadis, Azelis, Barco, Basic-Fit, Brunel International, DEME Group, Euronext, Fagron, Heijmans, Kinepolis, Lotus Bakeries, Melexis, Ontex, Randstad, Recticel, SBM Offshore, TKH Group, Van Lanschot Kempen Other company stories - OCI: Divestment of Methanol to Methanex for US$2.05bn, Staffing: US August temp volumes marginally better trend; NFP jobs miss
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.